Related Experiment Video
Updated: Sep 8, 2025

05:37
Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
Published on: October 20, 2023
1.6K
Optimization of measurements with an ultrasound attenuation coefficient algorithm for quantifying liver fat
Giovanna Ferraioli1, Davide Roccarina2,3, Takashi Kumada4
1Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Campus della Salute, Pavia, Italy.
European Radiology
|September 5, 2025
Summary
Optimizing ultrasound attenuation coefficient (AC) measurements for liver fat assessment is crucial. A movable region of interest (ROI) placed 25 mm below the liver capsule significantly improves AC correlation with MRI-PDFF and diagnostic performance.
Area of Science:
- Medical Imaging
- Ultrasound Technology
- Hepatology
Background:
- Ultrasound attenuation coefficient (AC) measurement methods vary, impacting liver fat assessment accuracy.
- Fixed regions of interest (ROIs) may not be optimal for all patient anatomies.
- Comparing fixed vs. movable ROIs is essential for improving ultrasound-based liver steatosis detection.
Purpose of the Study:
- To evaluate if a movable ROI improves ultrasound AC measurement correlation with MRI proton density fat fraction (MRI-PDFF).
- To assess the impact of ROI positioning on the diagnostic performance of AC measurements for liver steatosis.
- To determine the optimal placement for a movable ROI in ultrasound AC measurements.
Main Methods:
- Retrospective multicenter study involving 750 participants.
- Ultrasound AC measurements using an Arietta 850 system with stored raw data.
- Reprocessing data with a standard fixed ROI (35-75 mm), a shorter fixed ROI (45-75 mm), and movable ROIs (30 mm length) positioned at 20 mm and 25 mm below the liver capsule.
- Correlation analysis with MRI-PDFF using Spearman rho and performance assessment via AUROC.
Main Results:
- A movable ROI positioned 25 mm below the liver capsule (ROI-setting4) showed the highest correlation with MRI-PDFF (0.80).
- ROI-setting4 demonstrated superior performance across all steatosis grades, with AUROC for S>0 of 0.92.
- This optimal movable ROI setting significantly outperformed others in participants with obesity and skin-to-liver distances > 25 mm.
Conclusions:
- A movable ROI significantly enhances both the correlation between ultrasound AC and MRI-PDFF and the diagnostic performance for liver steatosis.
- Optimal performance is achieved with a movable ROI positioned 25 mm below the liver capsule.
- Fixed ROI methods may lead to decreased performance, particularly in patients with greater skin-to-liver distances.

